Molecular cytogenetic techniques are used for the diagnosis of several diseases such as leukemia, cancer, chronic diseases, and certain genetic disorders. Previously, conventional cytogenetics were only used to detect chromosomal abnormalities in arrangements. However, with the advent of FISH and CGH, it has become possible to detect both numerical and structural cytogenetic changes.

PART 01: Executive summary

PART 02: Scope of the report  

PART 03: Research Methodology

PART 04: Introduction

Overview

Market size and forecast

Five forces analysis

PART 05: Segmentation by end-users

Overview

Clinical and research laboratories

Pharmaceutical and biotechnology companies

Others

PART 06: Segmentation by geography

Overview

Americas

EMEA

APAC

PART 07: Decision framework

PART 08: Drivers and challenges

Market drivers

Market challenges

PART 09: Market trends

Increased focus on targeted cancer treatment

Rising demand in emerging markets

Transition from FISH to array-based technique

PART 10: Vendor landscape

Competitive scenario

Investment opportunity

PART 11: Key vendor analysis

Abbott Laboratories

Agilent Technologies

Bio-Rad Laboratories

Thermo Fisher Scientific

Other prominent vendors

PART 12: Appendix

List of abbreviations

PART 13: Explore Technavio